The protooncogene c-fps/fes is a single vertebrate locus homologous to both the fps transforming gene of Fujinami avian sarcoma virus and thefes transforming gene of two feline sarcoma virus isolates. The human c-fps/fes locus has been previously cloned and characterized. We report that a recombinant gene in which 3' human c-fps/fes sequences replace over 80% of the feline sarcoma virusfes sequences transforms NIH 3T3 mouse fibroblasts and encodes a protein kinase. Cells transformed by this recombinant possess increased phosphotyrosine levels. These observations demonstrate that a large carboxyl portion of a human c-fps/fes protein product can functionally complement a retroviral transforming protein.
Several highly conserved cellular genes, called protooncogenes or c-onc genes, induce rapid malignancies in animals when transduced by retroviruses (1, 2) . Some of these genes have been implicated in the genesis of a number of nonviral animal and human tumors (3) . The mechanism of activation of these genes to a transforming state is of central interest in understanding neoplastic processes. Moreover, studies of human c-onc gene activation may be relevant to clinically important malignant disease.
The Fujinami avian sarcoma virus (FSV) and the Gardner-Arnstein and Snyder-Theilen feline sarcoma viruses (GA-FeSV and ST-FeSV) have transduced host cell sequences (denoted fps and fes, respectively) that are necessary for their transforming ability (4, 5) . These sequences, fused to 5' viral gag sequences, encode tyrosine-specific protein kinases (6) (7) (8) (9) . The carboxyl portions of the FSV and FeSV transforming products exhibit homology at the protein level with other retroviral tyrosine kinases and a cAMP-dependent protein kinase (10) . Studies of deletion mutants have established the importance of thefes product's carboxyl half in transformation (4, 5) .
The genome of vertebrates possesses a single locus that was transduced independently by FSV, ST-FeSV, and GAFeSV (11) . The entire human region (c-fps/fes) homologous to the transforming genes of these retroviruses is located within a 14-kilobase (kb) EcoRI DNA fragment ( Fig. 1) (11, (13) (14) (15) . The regions of homology in the human genome are discontinuous, suggesting an exon-intron structure with a minimum of six exons homologous to the FSV transforming gene (v-fps) (11 (18, 19) .
NIH 3T3 Transformation Assays. NIH 3T3 transfections were performed as described (20) . For tests of anchorage independence, transfected cells were treated with trypsin 3 days after transfection and seeded into medium supplemented with 10% calf serum in the presence of xanthine and MPA as described (16 Both the cloned 14-kb human c-fps/fes fragment alone and the same fragment positioned 3' to strong transcriptional promoters (the SV40 early promoter and the GA-FeSV LTR) (Fig. 1, c- (12) . Viral fes sequences are illustrated by the black box. The structure of the cloned 14-kb EcoRI fragment containing the entire human c-fps/fes locus is shown (11, (13) (14) (15) (Fig. 2, lane 5) exhibited a transformed phenotype, the structure of the Rec-Kpn sequences in the MPA-resistant colonies was examined. A 14-kb EcoRI fragment and two 4.0-kb Xho I fragments, expected from integration of the intact recombinant locus, were detected in the DNA of transformed cells (Fig. 2, lanes 7 and  9) . Analysis of the integrated DNA of these clones by using several other restriction endonucleases indicated that no detectable rearrangements had occurred in the Rec-Kpn construct during transfection and integration (data not shown).
On the other hand, substantial alterations in the structure of the transfected Rec-Kpn plasmid were detected in the MPAresistant clones that were not transformed. In most cases, no fps/fes-honmologous DNA (except for faint hybridization to the endogenous mouse c-fps/fes locus at 6.0 kb) was detected ( Fig. 2, lanes 6 and 8) . In some cases substantial interruptions of the Rec-Kpn construct had occurred during integration or transfection in the untransformed clones.
Examination of the anchorage-independent Rec-Kpn transfectants forfes-related RNA species revealed the presence of a 4.5-kb RNA transcript that was detected by hybridization to DNA probes prepared from the GA-FeSV gag-fes region (Fig. 3, lane 6) . No fps/fes-related transcripts were observed in untreated NIH 3T3 cells or in MPA-resistant, untransformed clones that had been transfected with the Rec-Kpn DNA (Fig. 3, lanes 1 and 5) .
Protein Product of the Transforming Recombinant. To characterize the protein product of the Rec-Kpn gene, total cell protein lysates from transfected cells were immunoprecipitated by Uising monoclonal antibodies prepared against the p15 gag-and the v-fes-specific regions of the GA-FeSV p110 transforming protein (Fig. 4) (26) . A protein that migrates slightly slower on sodium dodecyl sulfate/polyacrylamide gels than does the p110 GA-FeSV transforming gene product was precipitated by anti-p1S gag and one of the antifes region monoclonal antibodies (F113) in the cells that were transformed by the Rec-Kpn construct. No such proteins were precipitated in extracts prepared from untreated NIH 3T3 cells or MPA-resistant cells that were not transformed but that had also been transfected with the Rec-Kpn construct. An additional monoclohal antibody prepared against the GA-FeSV pi10 protein that recognizes fes-specific determinants (F123) did not immunoprecipitate a protein from the Rec-Kpn-transformed cells (26) . These data demonstrate that the Rec-Kpn chimeric product possesses fes-encoded antigenic determinants, some similar to and some different from those of the GA-FeSV p110.
In Vitro Protein Kinase Activity. Immunoprecipitated GAFeSV p110 possesses the ability to phosphorylate a tyrosine residue near its carboxyl terminus in vitro (9, 27) . This function depends on intrinsic kinase ability and a seven amino acid recognition sequence near the phosphorylated tyrosine that is conserved in retroviral transforming proteins with tyrosine kinase activity (10, 28, 29) . The phosphorylation of p110 is readily seen after immuhoprecipitation with anti-p1S gag monoclonal antibodies, but the activity is markedly reduced when anti-fes monoclonal antibodies are used (26) . To Stephenson), goat anti-rat immunoglobulin G, and staphylococcal protein A-Sepharose (Pharmacia) as described (26) . Precipitates were washed and subjected to electrophoresis on sodium dodecyl sulfate/polyacrylamide gels as described (26) . kDa, Kilodaltons. Immunoprecipitates formed by using monoclonal antibodies F113 (anti-v-fes) (lanes 1-6), F72 (anti-p15 gag) (lanes 7-11), F40 (which recognizes a p30 gag determinant not found in the GA-FeSV polyprotein (lane 12), and F123 (anti-v-fes) (lane 13) are shown. Cell lysates were derived from NIH 3T3 cells transfected with pSV2gpt alone (lanes 1 and 7) ; GA-FeSV (lane 2); Rec-Kpn, MPA resistant, but untransformed ( lanes 3 and 8) ; Rec-Kpn, MPA resistant and transformed (lanes 4, 9, 12, and 13); Rec-Kpn focus (lanes 5 and 10) (6-9, 28, 29) . To determine whether the Rec-Kpn product might possess tyrosine kinase activity in cells, total phosphotyrosine in the cells transformed by this recombinaht was examined. the transfected cells that had lost the Rec-Kpn gene, higher levels are observed in cells transformed by Rec-Kpn or GAFeSV. We conclude that the Rec-Kpn product is responsible for this phosphotyrosine increase.
Reduced Transforming Efficiency of the Rec-Kpn Gene. Some of the factors potentially responsible for the lower transforming efficiency of Rec-Kpn compared to the cloned GA-FeSV provirus were examined. In-phase substitution of Rec-Kpn c-fps/fes sequences 3' to a conserved Pst I site with analogous GA-FeSV sequences (Fig. 1, Rec-2 ) did not increase transformation efficiency. Thus, some of the cfps/fes sequences determining lower transformation efficiency lie between the Kpn I and Pst I sites used to construct Rec-2.
One observation suggesting that genetic instability or lethality of Rec-Kpn may contribute to low transformation efficiency is the high rate of reversion to the untrarnsformed state compared to that of GA-FeSV-transformed cells. Analysis of reverted subclones revealed that whereas they remained resistant to MPA, they no longer contained seqUences homologous to the Rec-Kpn gene (Fig. 2, lane 11 ; Fig. 4 ). There may be some selection against the presence and expression of the recombinant in NIH 3T3 cells.
DISCUSSION
The results presented here indicate that a large 3' portion of the human c-fps/fes protooncogene can substitute functionally for the transforming region of the FeSV. In the oncogenic recombinant (Rec-Kpn) more than 80% of the fps/fes-homologous sequences necessary for fibroblast transformation are supplied by the human locus. The transfected cells possess a fully transformed phenotype, including focus-forming ability, anchorage independence, and tumorigenicity in nude mice. In addition, the transformants exhibit increased cellular phosphotyrosine levels. The Rec-Kpn product has associated protein kinase activity that is probably supplied by human determinants, which replace v-fps/fes regions exhibiting homology at the protein level to other retroviral tyrosine kinases (10) .
In our transforming recombinants, three types of structural changes in the human c-fps/fes locus were introduced, 30 and unpublished data) . The cloned 14-kb human fragment used in these studies is also transcriptionally silent when introduced into a murine cellular environment. This could be due to intrinsic properties of the human c-fps/fes promoter or to the absence of the promoter from our cloned fragment. Transcriptional activation is likely to be necessary for transformation. To determine whether it is sufficient will require more detailed characterization of the LTR c-fps construction and potential products translated from the 3.3-kb message observed in transfected cells.
(ii) Deletion of 5' portions of the protooncogene, including probable exon regions. Functional exclusion of protooncogene sequences, either by deletion or mutation, is a feature of their activation to a transforming state in many instances of retroviral transduction. Exclusion of protooncogene exons from the transforming v-onc gene may circumvent regulatory functions of the encoded domains on the c-onc product, allowing transformation.
(iii) Substitution of the 5' end of the protooncogene with viral translational initiation signals and AUG codon, gag determinants, and a small part of viral v-fes. Deletion of gag sequences does not appear to affect fibroblast transformation by the v-fps (31) or the Abelson murine leukemia virus v-abl gene, but in the latter case, gag sequences may be necessary for lymphocyte transformation (32) . The importance of viral gag and v-fes sequences to the activity of the transforming Rec-Kpn gene could be assessed by substitution of those sequences with an in-phase initiation codon. Further studies should delineate which of the structural changes in the human c-fps/fes gene are necessary for its conversion to a transforming state.
